Virginia G. Piper Cancer Center

The Virginia G. Piper Cancer Center (VGPCC) is a premier comprehensive cancer care and research facility located in Scottsdale, Arizona, and is a key component of the HonorHealth system. The center is internationally recognized for its Early Phase Clinical Trials Center, which specializes in first-in-human and Phase 1 oncology studies. Through a long-standing strategic partnership with the Translational Genomics Research Institute (TGen), VGPCC integrates advanced genomic sequencing into clinical practice to provide personalized treatment plans. The facility offers a multidisciplinary approach to oncology, encompassing radiation therapy, infusion services, and specialized centers for breast and pancreatic cancers. VGPCC has played a pivotal role in the clinical development of numerous FDA-approved therapies, most notably the combination of gemcitabine and nab-paclitaxel for advanced pancreatic cancer. Its research infrastructure serves as a critical hub for pharmaceutical and biotechnology companies seeking to advance novel therapeutic candidates through early-stage clinical development.